Literature DB >> 12737818

Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine.

G Jawahar Swaminathan1, Daniel E Holloway, Richard A Colvin, Gabriele K Campanella, Anastassios C Papageorgiou, Andrew D Luster, K Ravi Acharya.   

Abstract

We have determined the structure of wild-type IP-10 from three crystal forms. The crystals provide eight separate models of the IP-10 chain, all differing substantially from a monomeric IP-10 variant examined previously by NMR spectroscopy. In each crystal form, IP-10 chains form conventional beta sheet dimers, which, in turn, form a distinct tetrameric assembly. The M form tetramer is reminiscent of platelet factor 4, whereas the T and H forms feature a novel twelve-stranded beta sheet. Analytical ultracentrifugation indicates that, in free solution, IP-10 exists in a monomer-dimer equilibrium with a dissociation constant of 9 microM. We propose that the tetrameric structures may represent species promoted by the binding of glycosaminoglycans. The binding sites for several IP-10-neutralizing mAbs have also been mapped.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12737818     DOI: 10.1016/s0969-2126(03)00070-4

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  32 in total

1.  Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors.

Authors:  Prem Raj B Joseph; Jose M Sarmiento; Anurag K Mishra; Sandhya T Das; Roberto P Garofalo; Javier Navarro; Krishna Rajarathnam
Journal:  J Biol Chem       Date:  2010-07-14       Impact factor: 5.157

Review 2.  Structural NMR of protein oligomers using hybrid methods.

Authors:  Xu Wang; Hsiau-Wei Lee; Yizhou Liu; James H Prestegard
Journal:  J Struct Biol       Date:  2010-11-11       Impact factor: 2.867

Review 3.  Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function.

Authors:  C L Salanga; T M Handel
Journal:  Exp Cell Res       Date:  2011-01-09       Impact factor: 3.905

4.  NMR in the Analysis of Functional Chemokine Interactions and Drug Discovery.

Authors:  Joshua J Ziarek; Brian F Volkman
Journal:  Drug Discov Today Technol       Date:  2012

5.  Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4.

Authors:  Dianhua Jiang; Jiurong Liang; Gabriele S Campanella; Rishu Guo; Shuang Yu; Ting Xie; Ningshan Liu; Yoosun Jung; Robert Homer; Eric B Meltzer; Yuejuan Li; Andrew M Tager; Paul F Goetinck; Andrew D Luster; Paul W Noble
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

6.  Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans.

Authors:  India C Severin; Jean-Philippe Gaudry; Zoë Johnson; Andreas Kungl; Ariane Jansma; Bernd Gesslbauer; Barbara Mulloy; Christine Power; Amanda E I Proudfoot; Tracy Handel
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

7.  The emerging role of CXCL10 in cancer (Review).

Authors:  Mingli Liu; Shanchun Guo; Jonathan K Stiles
Journal:  Oncol Lett       Date:  2011-05-09       Impact factor: 2.967

Review 8.  CXCL10 activities, biological structure, and source along with its significant role played in pathophysiology of type I diabetes mellitus.

Authors:  Zahra Ahmadi; Mohammad Kazemi Arababadi; Gholamhossin Hassanshahi
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

9.  Changes in protein structure and distribution observed at pre-clinical stages of scrapie pathogenesis.

Authors:  Ariane Kretlow; Qi Wang; Michael Beekes; Dieter Naumann; Lisa M Miller
Journal:  Biochim Biophys Acta       Date:  2008-06-14

10.  Structure of mouse IP-10, a chemokine.

Authors:  Talat Jabeen; Philip Leonard; Haryati Jamaluddin; K Ravi Acharya
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2008-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.